Furthermore, the expression of TIGIT is strongly correlated with NK cell exhaustion in CRC patients and tumor-bearing mice, and targeting the TIGIT signaling pathway in multiple tumor models has been shown to prevent NK cell exhaustion and enhance their antitumor immune responses [148]. Here, TIGIT is linked to neoplasm.